Medirom Healthcare Technologies Inc • MRM

Capital at risk.

About Medirom Healthcare Technologies Inc
Ticker
info
MRM
Trading on
info
NASDAQ
ISIN
info
US58510H1032
Industry
info
Personal Services
Sector
info
Consumer Cyclical
CEO
info
Kouji Eguchi
Headquarters
info
2-3-1 Daiba, Tokyo, undefined, Japan, 135 0091
Employees
info
334
Website
info
https://medirom.co.jp
MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment develops, owns, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program that utilizes Lav, an on-demand health monitoring smartphone application, as well as MOTHER Bracelet for fitness and health applications; and provides preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. The company also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Metrics
BasicAdvanced
Market cap
info
$16.1M
P/E ratio
info
5.37
EPS
info
$0.38
Dividend Yield
info
0.00%
Beta
info
0.95
Forward P/E ratio
info
0
EBIDTA
info
$149M
Ex dividend date
info
-
Price & volume
Market cap
info
$16.1M
Average daily volume
info
0.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
5.37
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
5.37
Price to sales
info
0
Price to book
info
10.35
Earnings
EPS
info
$0.38
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$149M
Revenues (TTM)
info
$8.07B
Revenues per share (TTM)
info
$1,221.72
Technicals
Beta
info
0.95
52-week High
info
$3.70
52-week Low
info
$0.34
50-day moving average
info
$2.13
200-day moving average
info
$1.45
Short ratio
info
0.51
Short %
info
3.78%
Management effectiveness
ROE (TTM)
info
53.19%
ROA (TTM)
info
-1.78%
Profit margin
info
0.50%
Gross profit margin
info
$2.02B
Operating margin
info
-25.84%
Growth
Quarterly earnings growth (YoY)
info
27.80%
Quarterly revenue growth (YoY)
info
-6.70%
Share stats
Outstanding Shares
info
7.9M
Float
info
5.8M
Insiders %
info
26.42%
Institutions %
info
2.08%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$5.12
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.48
-
-
Q4 • 20Beat
-$0.48
-
-
Q1 • 21Beat
-$118.56
-
-
Q3 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$3.48B
$-582M
-16.75%
Q2 • 24
$4.82B
$731M
15.15%
Q1 • 25
38.80%
-225.55%
-190.45%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$8.09B
$6.9B
85.32%
Q4 • 24
$8.09B
$6.9B
85.32%
Q1 • 25
0.00%
0.00%
0.00%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-786M
-
$60.8M
$-804M
Q2 • 24
$-546M
-
$1.13B
$-1.09B
Q1 • 25
-30.51%
-
1,763.09%
35.76%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Medirom Healthcare Technologies Inc share?
Collapse

Medirom Healthcare Technologies Inc shares are currently traded for undefined per share.

How many shares does Medirom Healthcare Technologies Inc have?
Collapse

Medirom Healthcare Technologies Inc currently has 7.9M shares.

Does Medirom Healthcare Technologies Inc pay dividends?
Collapse

No, Medirom Healthcare Technologies Inc doesn't pay dividends.

What is Medirom Healthcare Technologies Inc 52 week high?
Collapse

Medirom Healthcare Technologies Inc 52 week high is $3.70.

What is Medirom Healthcare Technologies Inc 52 week low?
Collapse

Medirom Healthcare Technologies Inc 52 week low is $0.34.

What is the 200-day moving average of Medirom Healthcare Technologies Inc?
Collapse

Medirom Healthcare Technologies Inc 200-day moving average is $1.45.

Who is Medirom Healthcare Technologies Inc CEO?
Collapse

The CEO of Medirom Healthcare Technologies Inc is Kouji Eguchi.

How many employees Medirom Healthcare Technologies Inc has?
Collapse

Medirom Healthcare Technologies Inc has 334 employees.

What is the market cap of Medirom Healthcare Technologies Inc?
Collapse

The market cap of Medirom Healthcare Technologies Inc is $16.1M.

What is the P/E of Medirom Healthcare Technologies Inc?
Collapse

The current P/E of Medirom Healthcare Technologies Inc is 5.37.

What is the EPS of Medirom Healthcare Technologies Inc?
Collapse

The EPS of Medirom Healthcare Technologies Inc is $0.38.

What is the PEG Ratio of Medirom Healthcare Technologies Inc?
Collapse

The PEG Ratio of Medirom Healthcare Technologies Inc is null.

What do analysts say about Medirom Healthcare Technologies Inc?
Collapse

According to the analysts Medirom Healthcare Technologies Inc is considered a buy.